Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Giles

Showing results (271-280 of 676) with videos related to

Pageof 68
Sort By:
Dalton Transactions (Cambridge, England : 2003)|September 14, 2013
Oxo-carboxylato-molybdenum(VI) complexes possessing dithiolene ligands related to the active site of type II DMSOR family molybdoenzymesHideki Sugimoto, Masanori Sato, Logan J Giles, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|March 1, 2025
Prediction models for intrapartum fetal hypoxia: A systematic reviewHolly J Giles-Clark, Sasha M Skinner, May M Linn, et al.
Cancer|January 29, 2000
Expression of thrombopoietin and its receptor (c-mpl) in chronic myelogenous leukemia: correlation with disease progression and response to therapyK Kaban, H Kantarjian, M Talpaz, et al.
Cancer|February 25, 2003
Increased telomerase activity is associated with shorter survival in patients with chronic phase chronic myeloid leukemiaSrdan Verstovsek, Hagop Kantarjian, Taghi Manshouri, et al.
Journal of Patient Safety|March 19, 2019
Capturing Patients' Perspectives on Medication Safety: The Development of a Patient-Centered Medication Safety FrameworkSally J Giles, Penny J Lewis, Denham L Phipps, et al.
Cancer Treatment and Research|April 22, 2015
Synthetic high-density lipoprotein-like nanoparticles as cancer therapyKaylin M McMahon, Linda Foit, Nicholas L Angeloni, et al.
Expert Opinion on Drug Delivery|December 22, 2007
Trends in immunoconjugate and ligand-receptor based targeting development for cancer therapyMichael J Brumlik, Benjamin J Daniel, Reinhard Waehler, et al.
Cancer Management and Research|June 28, 2017
Clinical features, diagnostic challenges, and management strategies in checkpoint inhibitor-related pneumonitisSarah Chuzi, Fabio Tavora, Marcelo Cruz, et al.
Cancer Genetics and Cytogenetics|October 15, 1988
Granulocytic sarcoma of the small intestine preceding acute myelomonocytic leukemia with abnormal eosinophils and inv(16)S J Russell, F J Giles, D S Thompson, et al.
Oncology (Williston Park, N.Y.)|April 18, 2016
Is Personalized Medicine Here?Benedito A Carneiro, Ricardo Costa, Timothy Taxter, et al.
Pageof 68

Showing results (271-280 of 676) with videos related to

Sort By:
Pageof 68
Dalton Transactions (Cambridge, England : 2003)|September 14, 2013
Oxo-carboxylato-molybdenum(VI) complexes possessing dithiolene ligands related to the active site of type II DMSOR family molybdoenzymesHideki Sugimoto, Masanori Sato, Logan J Giles, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|March 1, 2025
Prediction models for intrapartum fetal hypoxia: A systematic reviewHolly J Giles-Clark, Sasha M Skinner, May M Linn, et al.
Cancer|January 29, 2000
Expression of thrombopoietin and its receptor (c-mpl) in chronic myelogenous leukemia: correlation with disease progression and response to therapyK Kaban, H Kantarjian, M Talpaz, et al.
Cancer|February 25, 2003
Increased telomerase activity is associated with shorter survival in patients with chronic phase chronic myeloid leukemiaSrdan Verstovsek, Hagop Kantarjian, Taghi Manshouri, et al.
Journal of Patient Safety|March 19, 2019
Capturing Patients' Perspectives on Medication Safety: The Development of a Patient-Centered Medication Safety FrameworkSally J Giles, Penny J Lewis, Denham L Phipps, et al.
Cancer Treatment and Research|April 22, 2015
Synthetic high-density lipoprotein-like nanoparticles as cancer therapyKaylin M McMahon, Linda Foit, Nicholas L Angeloni, et al.
Expert Opinion on Drug Delivery|December 22, 2007
Trends in immunoconjugate and ligand-receptor based targeting development for cancer therapyMichael J Brumlik, Benjamin J Daniel, Reinhard Waehler, et al.
Cancer Management and Research|June 28, 2017
Clinical features, diagnostic challenges, and management strategies in checkpoint inhibitor-related pneumonitisSarah Chuzi, Fabio Tavora, Marcelo Cruz, et al.
Cancer Genetics and Cytogenetics|October 15, 1988
Granulocytic sarcoma of the small intestine preceding acute myelomonocytic leukemia with abnormal eosinophils and inv(16)S J Russell, F J Giles, D S Thompson, et al.
Oncology (Williston Park, N.Y.)|April 18, 2016
Is Personalized Medicine Here?Benedito A Carneiro, Ricardo Costa, Timothy Taxter, et al.
Pageof 68